NCT06153667 2026-04-01
BETTER-UAE
Merit Medical Systems, Inc.
Recruiting
Clinical Trials
10 trialsNCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
NCT05448365 2026-02-12
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Lo.Li.Pharma s.r.l
Phase NA Recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT07378098 2026-01-30
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
JW Pharmaceutical
Phase 3 Recruiting
NCT07078682 2025-09-12
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Zenchi, Inc.
Phase NA Recruiting
NCT05739123 2025-08-19
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Sumitomo Pharma Switzerland GmbH
Recruiting
NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
NCT05386615 2025-04-30
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
InSightec
Recruiting
NCT06392997 2025-01-23
GynRNA
ZIWIG
Recruiting